Search - Inserm - Institut national de la santé et de la recherche médicale Access content directly

Filter your results

3 Results
Structure: Internal structure identifier : 203854

Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France

Christos Chouaid , Lionel Bensimon , Emilie Clay , Aurélie Millier , Laurie Levy-Bachelot , et al.
Lung Cancer, 2019, 127, ⟨10.1016/j.lungcan.2018.11.008⟩
Journal articles hal-02273984v1
Image document

A prospective study of health care resource utilisation and selected costs of schizophrenia in France.

Emmanuelle Sarlon , Dirk Heider , Aurélie Millier , Jean-Michel Azorin , Hans-Helmut König , et al.
BMC Health Services Research, 2012, 12 (1), pp.269. ⟨10.1186/1472-6963-12-269⟩
Journal articles inserm-00735980v1

Predictive models to estimate utility from clinical questionnaires in ă schizophrenia: findings from EuroSC

Carole Siani , Christian De Peretti , Aurélie Millier , Laurent Boyer , Mondher Toumi
Quality of Life Research, 2016, 25 (4), pp.925-934. ⟨10.1007/s11136-015-1120-6⟩
Journal articles hal-01482545v1